We previously reported the efficacy of a multicomponent cognitive-behavioral intervention including biofeedback to decrease pain, affective distress, and objective measures of disease activity in patients with rheumatoid arthritis (RA).
In the present article we report evidence that this intervention is associated with reductions in RA-related clinic visits and days hospitalized as well as reductions in the costs of these medical services.
Data were independently and objectively collected over an 18-month interval as part of a controlled group outcome study.
The importance of documenting economic as well as clinical benefits of our treatments in specific patient populations is noted.
Mots-clés Pascal : Polyarthrite rhumatoïde, Chronique, Système ostéoarticulaire pathologie, Rhumatisme inflammatoire, Immunopathologie, Maladie autoimmune, Traitement, Douleur, Thérapie comportementale, Thérapie cognitive, Biofeedback, Programme thérapeutique, Efficacité traitement, Utilisation, Service santé, Etude longitudinale, Analyse coût, Economie santé, Homme
Mots-clés Pascal anglais : Rheumatoid arthritis, Chronic, Diseases of the osteoarticular system, Inflammatory joint disease, Immunopathology, Autoimmune disease, Treatment, Pain, Behavior therapy, Cognitive therapy, Biofeedback, Therapeutic schedule, Treatment efficiency, Use, Health service, Follow up study, Cost analysis, Health economy, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0536482
Code Inist : 002B18I07. Création : 01/03/1996.